Regulators in Japan had previously denied emergency approval for the Shionogi pill, saying they wanted to see more data on its effectiveness. There were also concerns the drug could pose risk to pregnancies, based on results from animal studies.
https://www.pharmalive.com/wp-content/uploads/2020/10/Japans-Shionogi-readies-COVID-19-vaccine-for-December-trial-CEO-Reuters-10-28-20.jpeg263370Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-11-22 05:51:372022-11-22 10:23:06Japan to grant emergency approval to Shionogi COVID-19 drug